Literature DB >> 31115466

Global geographic trends in antimicrobial resistance: the role of international travel.

Isabel Frost1,2, Thomas P Van Boeckel1,3, João Pires3, Jessica Craig1, Ramanan Laxminarayan1,4.   

Abstract

BACKGROUND: Rising antimicrobial resistance (AMR) is a threat to modern medicine, and increasing international mobility facilitates the spread of AMR. Infections with resistant organisms have higher morbidity and mortality, are costlier to treat, result in longer hospital stays and place a greater burden on health systems than infections caused by susceptible organisms. Here we review the role of travel in the international dissemination of AMR and consider actions at the levels of travelers, travel medicine practitioners and policymakers that would mitigate this threat.
RESULTS: Resistant pathogens do not recognize international borders; travelers to areas with high AMR prevalence are likely to be exposed to resistant bacteria and return to their home countries colonized. Medical tourists go between health facilities with drastically different rates of AMR, potentially transmitting highly resistant strains.Drug-resistant bacteria have been found in every continent; however, differences between countries in the prevalence of AMR depend on multiple factors. These include levels of antibiotic consumption (including inappropriate use), access to clean water, adequate sanitation, vaccination coverage, the availability of quality healthcare and access to high-quality medical products.
CONCLUSIONS: Travelers to areas with high levels of AMR should have vaccines up to date, be aware of ways of treating and preventing travelers' diarrhea (other than antibiotic use) and be informed on safe sexual practices. The healthcare systems of low- and middle-income countries require investment to reduce the transmission of resistant strains by improving access to clean water, sanitation facilities and vaccines. Efforts are needed to curb inappropriate antibiotic use worldwide. In addition, more surveillance is needed to understand the role of the movement of humans, livestock and food products in resistance transmission. The travel medicine community has a key role to play in advocating for the recognition of AMR as a priority on the international health agenda. KEY POLICY RECOMMENDATIONS: AMR is a threat to modern medicine, and international travel plays a key role in the spread of highly resistant strains. It is essential that this is addressed at multiple levels. Individual travelers can reduce antibiotic consumption and the likelihood of infection. Travelers should have up-to-date vaccines and be informed on methods of preventing and treating travelers' diarrhea, other than use of antibiotics and on safe sexual practices, such as condom use. Healthcare facilities need to be aware of the travel history of patients to provide appropriate treatment to those who are at high risk of exposure and to prevent further spread. Internationally, in countries without reliable and universal access to clean water, sanitation and hygiene, investment is needed to reduce the emergence and spread of resistance and ensure the antimicrobials available are of assured quality. High-income countries must ensure their use of antimicrobials is appropriate to reduce selection for AMR. Surveillance across all countries is needed to monitor and respond to this emerging threat. © International Society of Travel Medicine 2019. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ESBL; NDM; antimicrobial resistance; medical tourism; travel

Year:  2019        PMID: 31115466     DOI: 10.1093/jtm/taz036

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  50 in total

1.  Bacteriophage-Mediated Risk Pathways Underlying the Emergence of Antimicrobial Resistance via Intrageneric and Intergeneric Recombination of Antibiotic Efflux Genes Across Natural populations of Human Pathogenic Bacteria.

Authors:  Ekaterine Gabashvili; Saba Kobakhidze; Tamar Chkhikvishvili; Leila Tabatadze; Rusudan Tsiklauri; Ketevan Dadiani; Mamuka Kotetishvili
Journal:  Microb Ecol       Date:  2021-09-01       Impact factor: 4.552

2.  Anti-Methicillin-Resistant Staphylococcus aureus Activities of Artocarpus lakoocha Roxb Extract and Its Mode of Action.

Authors:  Punyisa Charirak; Khakhanang Ratananikom
Journal:  ScientificWorldJournal       Date:  2022-06-15

3.  Governing Antimicrobial Resistance (AMR) in a Changing Climate: A Participatory Scenario Planning Approach Applied to Sweden in 2050.

Authors:  Irene Anna Lambraki; Melanie Cousins; Tiscar Graells; Anaïs Léger; Sara Abdelrahman; Andrew P Desbois; Rose Gallagher; Birgitta Staaf Larsson; Bengt Mattson; Patrik Henriksson; Max Troell; Peter Søgaard Jørgensen; Didier Wernli; Carolee Anne Carson; Elizabeth Jane Parmley; Shannon Elizabeth Majowicz
Journal:  Front Public Health       Date:  2022-07-06

Review 4.  Antimicrobial Resistance Rates and Surveillance in Sub-Saharan Africa: Where Are We Now?

Authors:  Samuel Kariuki; Kelvin Kering; Celestine Wairimu; Robert Onsare; Cecilia Mbae
Journal:  Infect Drug Resist       Date:  2022-07-07       Impact factor: 4.177

5.  Identification of a broad-spectrum lytic Myoviridae bacteriophage using multidrug resistant Salmonella isolates from pig slaughterhouses as the indicator and its application in combating Salmonella infections.

Authors:  Mengfei Zhao; Rui Xie; Shuang Wang; Xi Huang; Hao Yang; Wenqing Wu; Lin Lin; Hongjian Chen; Jie Fan; Lin Hua; Wan Liang; Jianmin Zhang; Xiangru Wang; Huanchun Chen; Zhong Peng; Bin Wu
Journal:  BMC Vet Res       Date:  2022-07-12       Impact factor: 2.792

6.  Characterization of the First Carbapenem-Resistant Pseudocitrobacter faecalis Harboring blaOXA-181 in China.

Authors:  Qingyu Shi; Yan Guo; Yang Yang; Shi Wu; Renru Han; Li Ding; Dandan Yin; Fupin Hu
Journal:  Antibiotics (Basel)       Date:  2022-05-30

7.  European hospitals as source of multidrug-resistant bacteria: analysis of travellers screened in Finland after hospitalization abroad.

Authors:  Mikael Kajova; Tamim Khawaja; Anu Kantele
Journal:  J Travel Med       Date:  2022-07-14       Impact factor: 39.194

Review 8.  Vaccines Against Antimicrobial Resistance.

Authors:  Roberto Rosini; Sonia Nicchi; Mariagrazia Pizza; Rino Rappuoli
Journal:  Front Immunol       Date:  2020-06-03       Impact factor: 7.561

9.  Destination shapes antibiotic resistance gene acquisitions, abundance increases, and diversity changes in Dutch travelers.

Authors:  Alaric W D'Souza; Manish Boolchandani; Sanket Patel; Gianluca Galazzo; Jarne M van Hattem; Maris S Arcilla; Damian C Melles; Menno D de Jong; Constance Schultsz; Gautam Dantas; John Penders
Journal:  Genome Med       Date:  2021-06-07       Impact factor: 11.117

10.  Building Social-Ecological System Resilience to Tackle Antimicrobial Resistance Across the One Health Spectrum: Protocol for a Mixed Methods Study.

Authors:  Irene Anna Lambraki; Shannon Elizabeth Majowicz; Elizabeth Jane Parmley; Didier Wernli; Anaïs Léger; Tiscar Graells; Melanie Cousins; Stephan Harbarth; Carolee Carson; Patrik Henriksson; Max Troell; Peter Søgaard Jørgensen
Journal:  JMIR Res Protoc       Date:  2021-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.